Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...

The smart money seems to be calling a bottom for the healthcare sector. That could mean it’s time for investors to start taking another look at the industry’s more beleaguered stocks. Since the start ...

--Pfizer's Chief Executive Albert Bourla plans to meet Starboard Value next week with at least one other director after the activist investor acquired a $1 billion stake in the healthcare company, the ...

In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio ...

Pfizer CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday, citing ...

Pfizer Inc.’s stock gained Monday after a report that activist investor Starboard Value has invested $1 billion in the drug ...

Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its ...

Pfizer shares have gained ground since a report over the weekend said that activist investor Starboard Value has taken a roughly $1 billion stake in the drug maker and is pushing for changes. Monitor ...